101 results
Page 5 of 6
10-K
EX-4.3
b1r3b 4f4wt4c
16 Feb 21
Annual report
4:11pm
10-K
r2impvyghvs23b
16 Feb 21
Annual report
4:11pm
8-K
EX-99.1
ow7v8d
16 Feb 21
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update
4:05pm
8-K
g4b 3ekov
7 Dec 20
Regulation FD Disclosure
6:06am
8-K
EX-99.1
msu6c
26 Oct 20
Nurix Therapeutics Announces Appointment of Robert Tjian as Chairman of Scientific Advisory Board and His Resignation from the Board of Directors
4:05pm
8-K
EX-99.1
38qp80x
14 Oct 20
Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update
4:05pm
10-Q
EX-3.2
e2he gf6ysnjwmjbacs
14 Oct 20
Quarterly report
4:02pm
10-Q
sv6gdnnw30j7bxeq
14 Oct 20
Quarterly report
4:02pm
8-K
EX-99.1
80wm1t3np85 4sk
14 Oct 20
Regulation FD Disclosure
2:01pm
424B4
dh17z5nqwui
24 Jul 20
Prospectus supplement with pricing info
4:06pm
S-1/A
EX-3.4
8s0b2
20 Jul 20
IPO registration (amended)
6:32am
S-1/A
nqslwize 6di1sn
20 Jul 20
IPO registration (amended)
6:32am
S-1/A
EX-1.1
wqo6btx
20 Jul 20
IPO registration (amended)
6:32am
S-1
EX-10.9
e01y kedism5tlp7
2 Jul 20
IPO registration
4:04pm
S-1
lnuay
2 Jul 20
IPO registration
4:04pm
S-1
EX-10.10
plndv0 630mf
2 Jul 20
IPO registration
4:04pm
DRS/A
qaxjxm9sin0
10 Jun 20
Draft registration statement (amended)
12:00am
DRS
EX-10.9
dba0541c
5 May 20
Draft registration statement
12:00am
DRS
EX-10.10
qa9r2 so91eqxp
5 May 20
Draft registration statement
12:00am